Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Response of circulating heat shock protein 70 and anti-heat shock protein 70 antibodies to catheter ablation of atrial fibrillation.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, 2003-
    • الموضوع:
      Catheter Ablation*; Atrial Fibrillation/*therapy ; Autoantibodies/*blood ; HSP70 Heat-Shock Proteins/*blood; Aged ; Atrial Fibrillation/blood ; Female ; Follow-Up Studies ; HSP70 Heat-Shock Proteins/immunology ; Humans ; Male ; Middle Aged ; Pilot Projects
    • نبذة مختصرة :
      Background: This pilot study investigated the association between heat shock protein 70 (HSP70) and anti-HSP70 antibodies as well as their changes and rhythm outcome after atrial fibrillation (AF) catheter ablation.
      Methods: We studied 67 patients with AF (59±11 years, 66% male, 66% lone AF) undergoing catheter ablation. Circulating HSP70 and anti-HSP70 antibody levels were quantified using commercially available assays before and 6 months after catheter ablation. Serial 7-day Holter ECGs were used to detect AF recurrences.
      Results: At baseline, HSP70 was detectable in 14 patients (21%), but there was no correlation between clinical or echocardiographic variables and the presence or the level of HSP70. In contrast, patients with paroxysmal AF (n=39) showed lower anti-HSP70 antibodies (median [IQR] of 43 [28 - 62] μg/ml) than patients with persistent AF (n=28; 53 [41 - 85] μg/ml, p=0.035). Using multivariable regression analysis, AF type was the only variable associated with anti-HSP70 antibodies (Beta=0.342, p=0.008). At 6 months, HSP70 was present in 27 patients (41%, p<0.001 vs. baseline). Similarly, there was an increase of anti-HSP70 antibodies (48 [36 - 72] vs. 57 [43 - 87] μg/ml, p<0.001). AF recurrence rates were higher in patients with HSP70 increase ≥0.025 ng/ml (32 vs. 11%, p=0.038) or anti-HSP70 increase ≥2.5 μg/ml (26 vs. 4%, p=0.033).
      Conclusions: HSP70 and anti-HSP70 antibodies may - at least in part - be associated in the progression of AF and AF recurrence after catheter ablation.
    • References:
      Eur J Heart Fail. 2006 Dec;8(8):810-5. (PMID: 16714144)
      J Mol Cell Cardiol. 2007 Nov;43(5):616-26. (PMID: 17884089)
      Europace. 2008 Apr;10(4):444-9. (PMID: 18339614)
      Saudi Med J. 2007 Jun;28(6):844-7. (PMID: 17530097)
      J Am Coll Cardiol. 2010 Feb 23;55(8):725-31. (PMID: 20170808)
      Am J Cardiol. 2010 Feb 15;105(4):495-501. (PMID: 20152244)
      Circ Res. 2003 Jun 27;92(12):e87-100. (PMID: 12775586)
      Int J Cardiol. 2004 Sep;96(3):397-401. (PMID: 15301893)
      J Am Coll Cardiol. 2008 Feb 26;51(8):802-9. (PMID: 18294563)
      Toxicology. 2009 Jun 16;260(1-3):84-96. (PMID: 19464573)
      J Biol Chem. 2002 Apr 26;277(17):15107-12. (PMID: 11842086)
      Ann Thorac Surg. 2005 Mar;79(3):865-71; discussion 871. (PMID: 15734396)
      Heart Rhythm. 2010;7(2):157-64. (PMID: 20036199)
      Circ Res. 1994 Dec;75(6):1078-85. (PMID: 7525102)
      Eur Heart J. 2004 Jul;25(13):1108-15. (PMID: 15231368)
      Cell Stress Chaperones. 2009 Jan;14(1):105-11. (PMID: 18663603)
      Cardiology. 2008;110(1):45-52. (PMID: 17934269)
      Europace. 1999 Jan;1(1):35-9. (PMID: 11220537)
      Cardiovasc Surg. 2002 Jun;10(3):228-32. (PMID: 12044430)
      Circ Res. 2006 Dec 8;99(12):1394-402. (PMID: 17110598)
      Am Heart J. 2005 Mar;149(3):489-96. (PMID: 15864238)
      Heart Vessels. 2000;15(1):18-22. (PMID: 11001481)
      Europace. 2010 Oct;12(10):1360-420. (PMID: 20876603)
      J Am Coll Cardiol. 2007 Apr 17;49(15):1642-1648. (PMID: 17433956)
      Am Heart J. 2011 Jan;161(1):188-96. (PMID: 21167353)
      J Am Coll Cardiol. 2009 Sep 29;54(14):1309-16. (PMID: 19778674)
      Artif Organs. 2008 Nov;32(11):846-50. (PMID: 18959676)
      Nat Med. 2000 Apr;6(4):435-42. (PMID: 10742151)
      J Mol Cell Cardiol. 2006 Sep;41(3):555-62. (PMID: 16876820)
      Cardiovasc Res. 2001 Sep;51(4):637-46. (PMID: 11530097)
      Heart. 2005 Mar;91(3):299-304. (PMID: 15710705)
      Circulation. 2004 Oct 26;110(17):2588-90. (PMID: 15249499)
      J Clin Invest. 1997 Sep 1;100(5):1089-97. (PMID: 9276725)
    • الرقم المعرف:
      0 (Autoantibodies)
      0 (HSP70 Heat-Shock Proteins)
    • الموضوع:
      Date Created: 20130226 Date Completed: 20130809 Latest Revision: 20211021
    • الموضوع:
      20240829
    • الرقم المعرف:
      PMC3599085
    • الرقم المعرف:
      10.1186/1479-5876-11-49
    • الرقم المعرف:
      23432758